Guardant Health, Inc. (GH)
168.66
-6.34
(-3.62%)
USD |
NASDAQ |
Nov 04, 16:00
166.66
-2.00
(-1.19%)
After-Hours: 20:00
Guardant Health Enterprise Value : 24.03B for Nov. 3, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 03, 2026 | 24.03B |
| November 02, 2026 | 23.46B |
| October 30, 2026 | 24.53B |
| October 29, 2026 | 25.40B |
| October 28, 2026 | 25.04B |
| October 27, 2026 | 24.43B |
| October 26, 2026 | 23.79B |
| October 23, 2026 | 23.23B |
| October 22, 2026 | 22.41B |
| October 21, 2026 | 22.91B |
| October 20, 2026 | 22.37B |
| October 19, 2026 | 21.74B |
| October 16, 2026 | 21.83B |
| October 15, 2026 | 22.81B |
| October 14, 2026 | 22.42B |
| October 13, 2026 | 22.30B |
| October 12, 2026 | 22.39B |
| October 09, 2026 | 23.02B |
| October 08, 2026 | 22.76B |
| October 07, 2026 | 23.13B |
| October 06, 2026 | 23.45B |
| October 05, 2026 | 25.66B |
| October 02, 2026 | 24.40B |
| October 01, 2026 | 23.99B |
| September 30, 2026 | 24.47B |
| Date | Value |
|---|---|
| September 29, 2026 | 24.39B |
| September 28, 2026 | 24.34B |
| September 25, 2026 | 24.33B |
| September 24, 2026 | 24.22B |
| September 23, 2026 | 24.20B |
| September 22, 2026 | 24.31B |
| September 21, 2026 | 23.87B |
| September 18, 2026 | 24.61B |
| September 17, 2026 | 25.11B |
| September 16, 2026 | 24.01B |
| September 15, 2026 | 24.11B |
| September 14, 2026 | 23.07B |
| September 11, 2026 | 21.67B |
| September 10, 2026 | 21.89B |
| September 09, 2026 | 22.39B |
| September 08, 2026 | 22.15B |
| September 04, 2026 | 22.21B |
| September 03, 2026 | 22.16B |
| September 02, 2026 | 22.43B |
| September 01, 2026 | 22.61B |
| August 31, 2026 | 21.89B |
| August 28, 2026 | 22.22B |
| August 27, 2026 | 23.16B |
| August 26, 2026 | 23.48B |
| August 25, 2026 | 22.68B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Natera, Inc. | 54.96B |
| Quest Diagnostics, Inc. | 33.06B |
| Labcorp Holdings, Inc. | 35.27B |
| OPKO Health, Inc. | 1.380B |
| Psychemedics Corp. | -- |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -120.14M |
| Revenue (Quarterly) | 334.98M |
| Total Expenses (Quarterly) | 455.12M |
| EPS Diluted (Quarterly) | -0.9042 |
| Gross Profit Margin (Quarterly) | 65.39% |
| Profit Margin (Quarterly) | -35.87% |
| Earnings Yield | -2.07% |
| Normalized Earnings Yield | -2.029 |